Qiagen NV at Jefferies Healthcare Conference (Virtual) Transcript
Good morning, and good afternoon to those of you joining us from Europe. My name is Peter Welford. I'm the European pharma and biotech and life sciences analyst at Jefferies in London.
It's my great pleasure to introduce the next company in this track, which is QIAGEN. And it's our great pleasure to have here to join us today the CEO, Thierry Bernard. He's going to talk us through a few brief moments of introduction, and then we'll go straight into the fireside chat.
And with that, I'll pass over to Thierry, and thank you very much for joining us. Thank you.
No, thanks for having me, Peter, and good morning, good afternoon to everybody on the line, and thanks for the interest in QIAGEN.
Just in a few words, you have seen our earnings calls a couple of weeks ago. So what is of deep satisfaction for us as management of QIAGEN is that, first of all,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
